Houston Sleeve Surgeon

04/04/2026

GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal.

04/04/2026

12/01/2025

https://youtu.be/hK6YVTmMMpg?si=Peu3eJmJI7RiJl2Q

In this External Medicine Podcast interview, Mitch Belkin and Daniel Belkin speak with Dr. Johnson about fructose and its relationship to fat storage. They d...

11/24/2025

https://houstonsleevesurgeon.com/heartburn-after-vsg/

Learn why heartburn can occur after VSG surgery from bariatric experts in Houston, TX. Get guidance on prevention and care—schedule a consultation today.

10/15/2025

https://houstonsleevesurgeon.com/going-from-sleeve-to-bypass-how-much-weight-do-you-lose/

Considering a switch from sleeve to bypass? Learn how much weight you can lose at Houston Weight Loss and Sleeve Surgery Center in Houston, TX.

10/06/2025

https://houstonsleevesurgeon.com/robotic-gastric-sleeve-surgery/

Experience advanced precision with robotic gastric sleeve surgery at Houston Weight Loss and Sleeve Surgery Center in Houston, TX. Schedule today!

09/12/2025

https://houstonsleevesurgeon.com/optimizing-weight-loss-after-sleeve-gastrectomy/

Bariatric specialists in Houston, TX explain how sleeve gastrectomy supports lasting weight loss. Get expert guidance—schedule a consultation today.

11/19/2024

https://www.cnn.com/2024/11/17/health/video/ozempic-weight-loss-drugs-gupta-digvid

Sanjay Gupta, CNN’s chief medical correspondent, explains the effect weight loss drugs can have on your body.

05/21/2023

https://houstonsleevesurgeon.com/esg-or-once-weekly-injection-for-treatment-of-obesity/

In July 2022, two prospective randomized trials were published for two different treatment modalities for class one and two obesity (BMI between 30 and 40). One trial was published in the Lancet journal and the other trial was published in the New England Journal of Medicine. Endoscopic sleeve gastr...

01/01/2023

Learn more about services at Mayo Clinic.

11/21/2022

Ozempic, Wegovy, Saxenda…are injectable prescription medications that mimic the effects of Glucagon-like peptide-1 also known as GLP-1. GLP-1 is a gut hormone secreted by the intestines in response to food intake. It promotes weight loss, increases satiety, and stimulates insulin secretion while b...

09/30/2022

In major new genetic study:
👉⬆️ body fat occurs BEFORE ⬆️ calorie intake
👉obesity dependent on high insulin secretion
👉evidence for relevance to human (childhood) obesity
Result
👉"differs from the dogmatic view"
👉fulfills key predictions of the Carbohydrate-Insulin Model